Congratulations to Mr Polepole Pascal (centre top photo) a Master of Science Pathology student at the University of Zambia (UNZA) School of Medicine. He is the first awardee of the Moses Sinkala Memorial Zambia Endowed Award
One of the founding fathers of CIDRZ was Dr Moses Sinkala, then Director of the Lusaka Urban District Health Management Team. Sadly Dr Sinkala passed away far too soon, but his friends and colleagues at the UNZA School of Medicine and the University of Alabama at Birmingham Sparkman Center for Global Health wanted to honour his memory and recognize the extraordinary work that Dr Sinkala did to improve public health in Zambia. They have created the Moses Sinkala Memorial Zambia Endowed Award in his memory. This competitive award is available to any post graduate student in the UNZA SOM, and is decided by committee based on research that serves the public health needs of Zambia.
Charles Mpundu is Director General of the Zambian National Pension Scheme Authority (NAPSA).
Mr Mpundu has held many high level management positions in his career including: 1997-2001 General Manager of Cavmont Merchant Bank Ltd Zambia; 2001-2007 Director of Investments NAPSA; 2006-2012 Commissioner and CEO of Worker’s Compensation Fund Control Board Zambia; 2009-2012 Managing Director of Integral Initiatives Company Ltd. Zambia. In his current position at NAPSA he has responsibility of overseeing the national scheme with assets in excess of K9.5 billion (approx. US$1.5 billion).
Mr Mpundu is a member of the Institute of Directors Zambia, an Associate of the Chartered Institute of Arbitrators, UK and Zambia Branches, Chairman of the Barclays Bank Plc Staff Pension Trust Scheme, Non-Executive Director Zambeef Plc, President of the Actuarial Society of Zambia, Affiliate Member of the Institute of Actuaries, UK, and Vice Chair of the East and Central African Social Security Association (ECASSA). He holds a Master of Business Administration from Durham Business School, UK and a BSc in Actuarial Sciences from CASS Business School, City University, UK and is a trained Stockbroker and Licenced Investment Advisor.
Kondwa Emily Sakala-Chibiya is a legal practitioner and Advocate of the High Court and Supreme Court of Zambia.
Since 1999, Ms Sakala has been with Messrs. J.B. Sakala and Company in various positions. Since 2005 she has represented both corporate and private clients in matters relating to Labour, Company, Commercial, Family, Probate, and Contract Law, and Conveyancing. From 2003 to 2004 she worked with the Federation of International Women Lawyers (FIDA) providing legal advice to disadvantaged women and children in the areas of domestic violence, property rights, matrimonial and probate matters. She has served on multiple committees in relation to HIV/AIDS, women’s rights and gender-based violence, as well as audit and governance.
Ms Sakala holds a Bachelor of Laws Degree from Reading University, UK and was called to the Zambian Bar on 1995. In 2007 she obtained a certificate in Investment Advisory and Stock Broker Services from the Institute of Chartered Secretaries and the Zambia Centre for Accountancy Studies. Since 2010 she has been a Member of the Institute of Directors.
Patrick Wanjelani is Chief Executive Officer of Newgen Holdings Ltd, Zambia.
He is also Technical Advisor to IFAC Ethics Committee, and Director of Blue Light Risk Management Ltd and Kumil Investments Ltd.
Since 2001, Mr Wanjelani has been with Barclays Bank Zambia PLC in escalating positions of financial and governance responsibility. He most recently served as Head, Africa Asset Liability Management and Funds Transfer Policy of Barclays Africa Group Treasury implementing the funds transfer policy across 12 African entities; from 2005 to 2012 he was Chief Financial Officer for Barclays Bank Zambia PLC; and from 2001 to 2005 Mr Wanjelani served as Finance and Planning Manager.
He holds a Master of Business Administration from Oxford University, Association of Chartered Certified Accountants (ACCA) qualifications from Thames Valley University UK, and Diplomas in Professional Accounting and Business Administration, UK. Mr Wanjelani is a Fellow of Chartered and Certified Accountants.
Beatrice M Grillo is Managing Partner of Gadsden Grillo and Company.
Since 2003, Mrs Grillo has been a Partner, and then a Managing Partner, of Gadsden Grillo and Company. Previously she has held the post of Senior Accountant positions with DHL International Ltd, Indeco Ltd, and ZAPP Ltd.
She earned a BA Economics from the University of Zambia and a Diploma in Advanced Finance from the Netherlands. She is a Fellow of the Zambia Institute of Certified Accountants (FZICA) and a member of the Association of Certified Accountants (ACCA) UK.
She also serves as a member, or holds the Treasurer or Chairperson, on many Boards of Directors most notably the Non- Government Organisations Coordinating Council (NGOCC) for the past eight years.
Dr Mike Saag
Mike Saag is Professor of Medicine, Director of the William C. Gorgas Center for Geographic Medicine, and Director of the Center for AIDS Research at the University of Alabama at Birmingham (UAB).
Dr Saag developed the “1917 Clinic” in Birmingham, Alabama as an HIV outpatient clinic that provides comprehensive patient care in conjunction with the conduct of high quality clinical trials, basic science, and clinical outcomes research. 1917 is a clinical trials unit, data management center, and clinical specimen repository for the UAB Center for AIDS Research (CFAR).
Dr Saag focuses on HIV and Hepatitis C clinical, translational, and outcomes research. He has published over 300 articles in peer-reviewed journals, including multiple landmark firsts describing HIV genetic evolution and viral replication, and clinical practice of HIV patients including guidelines for use of viral loads and proof-of-concept of fusion inhibition as a therapeutic option. Mike also directed the first patient studies of seven of the 25 antiretroviral drugs currently on the market.
He is co-editor of the AIDS Therapy textbook, and editor of the Sanford Guides for Antimicrobial Agents and HIV. During his career Mike has served on many high-level Boards, and currently is a member of the International AIDS Society-USA Board of Directors and the HHS Guidelines Panel on Antiretroviral Therapy.
CIDRZ is pleased to announce that it has received a grant from The ELMA Foundation to help support the PREEMI Programme: Preterm Resources, Education and Effective Management for Infants. PREEMI will support implementation of proven and cost-effective antenatal and postnatal care interventions aimed at reducing perinatal morbidity and mortality among preterm infants. These are: use of antenatal corticosteroids and antibiotics for women and infants; provision of effective neonatal resuscitation and proper umbilical cord care; and supporting kangaroo-mother care (breastfeeding, bonding, and skin-to-skin contact). The overall aim of the programme is to support the Zambian Ministry of Health and Ministry of Community Development Mother and Child Health in realizing the goals of the recently adopted Newborn Health Framework by integrating the PREEMI package into the national rollout strategy. National coverage of these interventions could reduce neonatal mortality among preterm infants by 75%.
The PREEMI programme will include improving the quality of antenatal care services, particularly for women at increased risk of preterm delivery, through community and staff education, introduction of checklists and improved clinical record keeping, mentorship in clinical protocols and risk assessment, and provision of logistical support for clinical supplies and equipment. PREEMI trained nurses will be seconded to their respective health facilities, where they will serve as ‘Change Champions’ helping to implement proven interventions, coordinate trainings, provide daily onsite mentorship to health facility staff and monitor the programme.
CIDRZ’s Dr Albert Manasyan will be the Principal Investigator responsible for the PREEMI Programme.